Table 2.
Difference in average percent spent outpatient | 95% Confidence interval | p Value | |
---|---|---|---|
Crude | −3.3% | (−5.0, −1.6%) | <.001 |
Factor adjusted models | |||
GNRB complexitya | −2.5% | (−4.1, −0.9%) | .003 |
Posttransplant complicationsb | −1.4% | (−3.4, 0.6%) | .165 |
Pretransplant complexity factorsc | −2.7% | (−4.9, −0.5%) | .015 |
Fully adjusted modeld | −0.7% | (−3.5, 2.1%) | .608 |
Adjusted for binary indicator of multidrug resistance, fluoroquinolone resistance, polymicobial culture, presence of hard to treat organism, and time to culture collection.
Adjusted for severe GVHD (Grade 3 or more), neutropenia (500 cells/µl or less) at time of GNRB diagnosis, and inpatient at time of GNRB diagnosis.
Adjusted for age at transplant, donor type, HCT specific comorbidity index (HCT‐CI), conditioning regimen (myeloablative or nonmyeloablative, and underlying disease).
Adjusted for age at transplant, donor type, HCT specific comorbidity index (HCT‐CI), underlying disease, severe GVHD (Grade 3 or more), neutropenia (500 cells/µL or less) at time of GNRB diagnosis, conditioning regimen (myeloablative or nonmyeloablative, inpatient at time of GNRB diagnosis, polymicrobial indicator, and binary indicators of fluoroquinolone, and multidrug resistance)